RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:0 products available on ocs The medical channel is direct to consumer. That distribution platform allows them to keep all the revenue availble without having to share/split with the different channel partners.
They are correctly concentrating on product flowthrough with starseed first.
Yes, post harvest activities need efficiency improvements and that is being addressed and fixed.
Those of you who keep complaining about we need a executive with CPG experience do not understand what is being built.
If you don't understand how PBM's work in America, you should familiarize yourself. I have yet to read any constructive critic who has yet understood this.